Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Prevalence and predictors of antioxidant supplement use during breast cancer treatment
Cancer, 06/11/09
Greenlee H et al. - In a study to analyze the prevalence of and factors associated with antioxidant supplement use during breast cancer (BC) treatment, it was found that given the common use of antioxidant supplements during BC treatment, often at high doses and in conjunction with other complementary therapies, future research should address effects of antioxidant supplementation on BC outcomes.
Methods- From 2002 through 2004, women with BC who had participated a case-control study from 1996 to 1997 were invited to participate in a follow-up interview.
- Antioxidant supplement use was defined as any self-reported intake of supplemental vitamin C, vitamin E, β-carotene, or selenium in individual supplements or multivitamins.
- Follow-up interview participants were younger, more predominantly white, and of higher socioeconomic status than women who did not respond.
- Among 764 participants who completed the follow-up interview, 663 (86.8%) reported receiving adjuvant treatment for their BC.
- Of the 663 women, 401 (60.5%) reported using antioxidants during adjuvant treatment: 120 of 310 women (38.7%) used antioxidants during chemotherapy, 196 of 464 (42.2%) used them during radiation, and 286 of 462 (61.9%) used them during tamoxifen therapy.
- Of 401 antioxidant users, 278 women (69.3%) used high doses.
- Factors that were associated with high antioxidant supplement use during treatment were higher fruit and vegetable intake at diagnosis, tamoxifen use, ever using herbal products, and ever engaging in mind-body practices.
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
A phase 2 trial exploring the effects of high-dose (10,000 IU/day) Vitamin D3 in breast cancer patients with bone metastases
Cancer, 11/18/09
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions
Cancer Prevention Research, 11/09/09
Oral Cancer Prevention Advances with a Translational Trial of Green Tea
Cancer Prevention Research, 11/11/09
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 11/17/09
Activity of fulvestrant in HER2-overexpressing advanced breast cancer
Annals of Oncology, 11/06/09
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer
Annals of Oncology, 11/16/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


